An introduction to Selective laser trabeculoplasty

In his latest online article highly regarded ophthalmologist Mr Thomas Kersey gives us his insights into Selective Laser Trabeculoplasty. He explains the advancements in laser technology, the increased success rates of the procedure and the ongoing efforts being made to evaluate the long term-efficacy and safety of SLT studies.

What is Selective Laser Trabeculoplasty?

Selective laser trabeculoplasty (SLT) is a widely used and powerful method to treat glaucoma, which is a condition that can affect eyesight. In 2023, there have been some significant improvements in the field of SLT, increasing its efficiency and patient results.

Advancements in technology

Firstly, improved laser technology has increased the precision and targeting of SLT procedures. High-definition imaging systems, such as optical coherence tomography (OCT), now enable eye specialists to view the trabecular meshwork—the part of the eye that SLT targets—with more detail and accuracy. This ensures more accurate laser delivery and better treatment outcomes.

Also, research efforts have aimed at enhancing the treatment factors of SLT. Studies have explored the optimal laser energy level, pulse time, and spot size to increase the treatment effect and decrease negative effects. These advancements have led to higher success rates and fewer complications from SLT.

Another important update in SLT is, its use with other glaucoma treatments. Clinical trials looking at the combined effects of SLT and medication, such as prostaglandin analogues or beta blockers, have shown good results. The mix of treatments has shown better eye pressure control and it may lower the need for long-term medication use.

Ongoing Efforts

Ongoing efforts are being carried out to test the long-term efficiency and safety of SLT. Studies monitoring patients for long periods are essential in evaluating the persistence of treatment effects and learning possible late-onset complications. These findings will assist in enhancing SLT protocols and optimizing patient management strategies.

Researchers are working to assess the lasting effectiveness and security of SLT. Long-term follow-up of patients is crucial to measure the durability of treatment outcomes and identify potential delayed complications. These results will help to improve SLT procedures and refine patient care approaches.

Mr Thomas Kersey is a highly esteemed Ophthalmologist with over 20 years of experience in his field. If you would like to book an appointment with Mr Kersey you can on his Top Doctors profile today.